Hemostatic composite material and preparation method thereof
A technology of composite materials and thrombin, which is applied in the field of biomedical materials, can solve the problems of poor fluidity of fibrin composite powder, complicated clinical operation, complicated preparation process, etc., achieve antibacterial wound healing function, accelerate wound healing function, preparation method simple effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] A preparation method of a hemostatic composite material, comprising the steps of:
[0031] (1) Preparation of Component A: Ultrasonic dispersion of mesoporous silicon with a pore size of 25 nm and nanometer zinc oxide with a particle size of 30 nm in a solution containing coagulation factor XIII and fibrinogen, so that the content of the mesoporous silicon is 10mg / ml, the content of the nano-zinc oxide is 0.2mg / ml; then stirred at room temperature for 30 minutes, then suction filtered, and then vacuum-dried at 37°C for 150 minutes to obtain component A; In the solution of factor XIII and fibrinogen, the content of the coagulation factor XIII is 10IU / ml, and the content of the fibrinogen is 25mg / ml;
[0032] (2) Preparation of component B: ultrasonically disperse mesoporous silicon with a pore size of 25 nm and nano-zinc oxide with a particle size of 30 nm in a solution containing thrombin and calcium chloride, and make the content of the mesoporous silicon 10 mg / ml, t...
Embodiment 2
[0035] A preparation method of a hemostatic composite material, comprising the steps of:
[0036] (1) Preparation of Component A: Ultrasonic dispersion of mesoporous silicon with a pore size of 30nm and nano-zinc oxide with a particle size of 20nm in a solution containing coagulation factor XIII and fibrinogen, so that the content of the mesoporous silicon is 20mg / ml, the content of the nano-zinc oxide is 0.4mg / ml; then stirred at room temperature for 35 minutes, then suction filtered, and then vacuum-dried at 40°C for 130 minutes to obtain component A; In the solution of factor XIII and fibrinogen, the content of the coagulation factor XIII is 15IU / ml, and the content of the fibrinogen is 30mg / ml;
[0037](2) Preparation of component B: ultrasonically disperse mesoporous silicon with a pore size of 20 nm and nano-zinc oxide with a particle size of 60 nm in a solution containing thrombin and calcium chloride, and make the content of the mesoporous silicon 20 mg / ml, the conte...
Embodiment 3
[0040] A preparation method of a hemostatic composite material, comprising the steps of:
[0041] (1) Preparation of Component A: Ultrasonic dispersion of mesoporous silicon with a pore size of 20 nm and nanometer zinc oxide with a particle size of 50 nm in a solution containing coagulation factor XIII and fibrinogen, so that the content of the mesoporous silicon is 30mg / ml, the content of the nano-zinc oxide is 0.6mg / ml; then stirred at room temperature for 40 minutes, then suction filtered, and then vacuum-dried at 35°C for 150 minutes to obtain component A; In the solution of factor XIII and fibrinogen, the content of coagulation factor XIII is 20IU / ml, and the content of fibrinogen is 35mg / ml;
[0042] (2) Preparation of component B: ultrasonically disperse mesoporous silicon with a pore size of 30 nm and nano-zinc oxide with a particle size of 40 nm in a solution containing thrombin and calcium chloride, and make the content of the mesoporous silicon 30 mg / ml, the conte...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Aperture | aaaaa | aaaaa |
| Particle size | aaaaa | aaaaa |
| Aperture | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com


